• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [25318 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of two different implementation procedures to change clinicians practice roles in the detection of hereditary colorectal cancer]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of scalp cooling in the prevention of chemotherapy-induced hair loss]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)]
2022     Gesundheit Osterreich GmbH (GOeG) [Cost effectiveness of communication training for health care professionals]
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Cost effectiveness of a collaborative stepped care intervention for anxiety disorders in the primary care setting]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Cost effective analysis of negative pressure wound therapy for the treatment of venous ulcers in legs]
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Cost and budget impact analysis of an increase in day surgery for selected indications]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2013     Basque Office for Health Technology Assessment (OSTEBA) [CORREX® aortic valve bypass for treatment of severe aortic stenosis]
2024     Basque Office for Health Technology Assessment (OSTEBA) [Coronary sinus reducer stent for patients with refractory angina]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Coronary lithoplasty for coronary heart disease - Assessment according to §137h Social Code Book V]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Coronary lithoplasty for coronary heart disease - Addendum to commission H20-07]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Coronary intravascular lithotripsy in coronary artery disease]
2001     Finnish Office for Health Care Technology Assessment (Finohta) [Coronary angioplasty in Finland: an overview of the situation in 2000 and an estimation of needs in the near future]
2009     Committee for New Health Technology Assessment (CNHTA) [Corneal cross linking]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking with riboflavin in keratoconus]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking with riboflavin for keratoconus patients]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Corneal collagen crosslinking for keratoconus patients]
2015     Haute Autorite de sante (HAS) [Corneal collagen cross-linking and intrastromal corneal ring segments in the treatment of corneal ectasia]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Corifollitropin alfa (Elonva®) for controlled ovarian stimulation in assisted human reproductive techniques]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Core decompression: Evidence report for the S3 guideline on atraumatic femoral head necrosis in adults]
2021     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Coping strategies in complex medical situations - the example of coronary heart disease]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Conventional Or Magnetic resonance angiography after Endovascular Treatment of intracranial aneurysms (COMET)]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2026     Health Sciences Institute in Aragon (IACS) [Contrast-enhanced mammography in the diagnostic process of breast cancer]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Contraception: comparison of hormonal coils and copper coils]
2011     Finnish Office for Health Care Technology Assessment (Finohta) [Continuous wound infusion of local anaesthetic agents for postoperative analgesia]
2012     Finnish Office for Health Care Technology Assessment (Finohta) [Continuous subcutaneous insulin infusion in type 1 diabetes mellitus]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Continuous subcutaneous infusion pump for diabetic patients]
2013     The Swedish Council on Health Technology Assessment (SBU) [Continuous subcutaneous glucose monitoring for diabetes]
2010     Committee for New Health Technology Assessment (CNHTA) [Continuous local delivery of anesthesia to operative sites using an elastomeric infusion pump]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Continuous interstitial glucose monitoring (CGM) with real-time measurement devices in insulin-dependent diabetes mellitus]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Continuous flow registration for early detection of hepatic artery thrombosis after liver transplantation. Innovative technology reducing retransplantation rate?]
2009     Committee for New Health Technology Assessment (CNHTA) [Continuous femoral nerve block]
2005     Andalusian Health Technology Assessment Area (AETSA) [Continuous blood glucose monitoring system "GlucoWatch"]
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Continuous anaesthetic infusion system at the surgical site]
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Continuity of care]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Contaminants from the treatment of drinking water in the Autonomous Community of the Basque Country: Assessment of the risk and alternative treatments]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Consumer health information on smoking cessation options]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Consumer health information on lung cancer screening using low-dose computed tomography]
2011     Agenzia nazionale per i servizi sanitari regionali (Agenas) [Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]
2024     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Considerations related to risk treatment in the context of home care for older adults and courses of action to support care providers]
2008     Center for Medical Technology Assessment (CMT) [Consequences appearing to family carers]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Consensus recommendations on post-traumatic brain injury (TBI) rehabilitation]
2021     Health Sciences Institute in Aragon (IACS) [Congenital ventricular septal defect (VSD) treatment with percutaneous and periventricular insertion devices]
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Congenital hypothyroidism: clinical practice guideline]
2010     Andalusian Health Technology Assessment Area (AETSA) [Confocal microscopy in ophthalmology: Report summary of emergent technology]
2025     Institut national d'excellence en sante et en services sociaux (INESSS) [Confirmed trichomonas vaginalis infection: pharmacological treatment]
2009     Basque Office for Health Technology Assessment (OSTEBA) [Confidentiality of medical records. Analysis of the current situation and areas for improvement in their use and management]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Conductive intravesical chemohyperthermia with mitomycin in non-muscle invasive bladder cancer: review of guidelines and ongoing research]
2022     HTA South [Conductive education in cerebral palsy]
2023     Canary Health Service [Conduction system pacing implantation through electroanatomical mapping-guided vs. fluoroscopy]
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Conditions for regional implementation of a national careprogramme anxiety disorders, based on the multidisciplinary evidence based guideline on anxiety disorders]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia B) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia B) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia B) – Addendum to Project A25-56]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia A) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia A) – Benefit assessment according to §35a Social Code Book V]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concizumab (haemophilia A, haemophilia B) – Addendum to Projects A25-55 and A25-56]
2021     Gesundheit Osterreich GmbH (GOeG) [Concepts, indicators and measurement instruments for recording the impact of anti-stigma measures in mental health - quick assessment]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Concepts of care for people with dementia]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for valoctocogene roxaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for valoctocogene roxaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV): Evaluation of the study protocol (Version 1.0) and the statistical analysis plan (Version1.0) – Second addendum to Commission A22-20]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for risdiplam acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for fedratinib acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for etranacogene dezaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection for brexucabtagene autoleucel acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV): talquetamab (multiple myeloma)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV) – exagamglogene autotemcel (sickle cell disease)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV) – exagamglogene autotemcel (beta-thalassaemia)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – Valoctocogen roxaparvovec: review of the study protocol (version 2.0) and the statistical analysis plan (version 2.0) – 3. Addendum to project A22-20]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – Odronextamab (relapsed or refractory follicular lymphoma)]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – Odronextamab (relapsed or refractory DLBCL)]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – loncastuximab (DLBCL)]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – glofitamab (DLBCL)]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – epcoritamab (DLBCL)]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection – Belumosudil (chronic graft-versus-host disease)]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection - marstacimab (haemophilia A and B)]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection - iptacopan (paroxysmal nocturnal haemoglobinuria)]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection - epcoritamab (relapsed or refractory follicular lymphoma)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection - autologous anti-CD19-transduced CD3+ cells]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for a national health portal]
2009     The Swedish Council on Health Technology Assessment (SBU) [Computerized training for children with ADHD]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Computerized physician order entry - effectiveness and efficiency of electronic medication ordering with decision support systems]
2023     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [Computerized clinical decision support systems for decision support in patients with breast, lung, colorectal or prostate cancer]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Computerised axial tomography: equipments and use in the ACBC. Instructions on the appropriate use of CAT]
2008     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Computer-based cognitive behavioral therapy]
2007     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Computer-assisted surgery in knee surgery - a health technology assessment]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Computer-assisted minimally invasive total hip surgery (MIS): a randomised controlled trial into the effectiveness compared to traditional total hip arthroplasty (THA)]
2011     The Swedish Council on Health Technology Assessment (SBU) [Computer-Aided Detection (CAD) in mammography screening]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Computed tomography and its carcinogenic effects in children and youth in Québec]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Complications associated with the surgical instruments used in tonsillectomies]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Complex wound treatment: negative pressure therapy]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Complete exome sequencing in epileptic encephalopathy]
2010     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparison between ICPC (International Classification of Primary Care) classification and ICD (International Classification of Diseases) classification at primary care in Korea]
2024     HTA Region Stockholm [Comparing coronary computed tomography angiography (CCTA) to exercise electrocardiogram for suspected coronary artery disease: impact on patient outcomes]
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Comparative results of the different screening strategies used for T21, T18 and T13: adaptation of the EUnetHTA assessment]